Steven Swift to Middle Aged
This is a "connection" page, showing publications Steven Swift has written about Middle Aged.
Connection Strength
0.710
-
Genital Hiatus Size as a Predictor of Progression of Pelvic Organ Prolapse. Female Pelvic Med Reconstr Surg. 2021 06 01; 27(6):e555-e558.
Score: 0.054
-
What if you could not do a mid-urethral sling? Int Urogynecol J. 2019 09; 30(9):1387-1388.
Score: 0.047
-
Defining normal apical vaginal support: a relook at the POSST study. Int Urogynecol J. 2019 Jan; 30(1):47-51.
Score: 0.044
-
Standing Vs Supine; Does it Matter in Cough Stress Testing? Female Pelvic Med Reconstr Surg. 2017 Sep/Oct; 23(5):315-317.
Score: 0.042
-
Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013 Apr; 32(4):383-6.
Score: 0.029
-
Does neuromuscular blockade affect the assessment of pelvic organ prolapse? Int Urogynecol J. 2012 Nov; 23(11):1599-603.
Score: 0.029
-
Validation of Persian version of the Prolapse Quality-of-Life questionnaire (P-QOL). Int Urogynecol J. 2012 Feb; 23(2):229-33.
Score: 0.027
-
The inter-system association between the simplified pelvic organ prolapse quantification system (S-POP) and the standard pelvic organ prolapse quantification system (POPQ) in describing pelvic organ prolapse. Int Urogynecol J. 2011 Mar; 22(3):347-52.
Score: 0.026
-
Test-retest reliability of the cotton swab (Q-tip) test in the evaluation of the incontinent female. Int Urogynecol J. 2010 Aug; 21(8):963-7.
Score: 0.025
-
Validation of the Slovakian version of the P-QOL questionnaire. Int Urogynecol J. 2010 Jan; 21(1):53-61.
Score: 0.024
-
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study. Clin Drug Investig. 2009; 29(5):305-16.
Score: 0.023
-
Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Nov; 17(6):615-20.
Score: 0.019
-
Patient acceptance of medical student participation in an outpatient obstetric/gynecologic clinic. J Reprod Med. 2006 Feb; 51(2):109-14.
Score: 0.019
-
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005 Sep; 48(3):483-7.
Score: 0.018
-
Pelvic Organ Support Study (POSST) and bowel symptoms: straining at stool is associated with perineal and anterior vaginal descent in a general gynecologic population. Am J Obstet Gynecol. 2005 May; 192(5):1516-22.
Score: 0.018
-
Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005 Mar; 192(3):795-806.
Score: 0.018
-
Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol. 2003 Aug; 189(2):372-7; discussion 377-9.
Score: 0.016
-
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb; 14(1):50-4; discussion 54-5.
Score: 0.015
-
Case-control study of etiologic factors in the development of severe pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(3):187-92.
Score: 0.013
-
The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol. 2000 Aug; 183(2):277-85.
Score: 0.013
-
Test-retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet Gynecol. 1999 Jul; 94(1):99-102.
Score: 0.012
-
Transcultural translation and validation of the FIGO Assessment Scoring System (FASS) to Portuguese language. Int Urogynecol J. 2019 Jan; 30(1):131-137.
Score: 0.011
-
Comparison of pelvic organ prolapse in the dorsal lithotomy compared with the standing position. Obstet Gynecol. 1998 Jun; 91(6):961-4.
Score: 0.011
-
The reliability of performing a screening cystometrogram using a fetal monitoring device for the detection of detrusor instability. Obstet Gynecol. 1997 May; 89(5 Pt 1):708-12.
Score: 0.010
-
Intrasubject variability of the pressure-transmission ratio in patients with genuine stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996; 7(6):312-6.
Score: 0.009
-
Validation of the Polish version of P-QoL questionnaire. Ginekol Pol. 2016; 87(7):477-83.
Score: 0.009
-
Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol. 2016 Jan; 196:6-10.
Score: 0.009
-
Evaluation of current urodynamic testing methods in the diagnosis of genuine stress incontinence. Obstet Gynecol. 1995 Jul; 86(1):85-91.
Score: 0.009
-
Validation of the French version of the P-QoL questionnaire. Eur J Obstet Gynecol Reprod Biol. 2015 Sep; 192:10-6.
Score: 0.009
-
A comparison of stress leak-point pressure and maximal urethral closure pressure in patients with genuine stress incontinence. Obstet Gynecol. 1995 May; 85(5 Pt 1):704-8.
Score: 0.009
-
The FIGO assessment scoring system (FASS): a new holistic classification tool to assess women with pelvic floor dysfunction: validity and reliability. Int Urogynecol J. 2015 Jun; 26(6):859-64.
Score: 0.009
-
Validation of the Spanish-language version of the Prolapse Quality of Life questionnaire in Chilean women. Int Urogynecol J. 2015 Jan; 26(1):123-30.
Score: 0.009
-
Disability-adjusted life years (DALYs) in general population with pelvic organ prolapse: a study based on the prolapse quality-of-life questionnaire (P-QOL). Eur J Obstet Gynecol Reprod Biol. 2014 Nov; 182:22-6.
Score: 0.008
-
Body image in the Pelvic Organ Prolapse Questionnaire: development and validation. Am J Obstet Gynecol. 2014 Aug; 211(2):174.e1-9.
Score: 0.008
-
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder. BJU Int. 2013 Aug; 112(3):373-85.
Score: 0.008
-
Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. Int Urogynecol J. 2011 Jun; 22(6):645-50.
Score: 0.007
-
An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) & grafts in female pelvic floor surgery. Int Urogynecol J. 2011 Jan; 22(1):3-15.
Score: 0.007
-
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011 Jan; 30(1):2-12.
Score: 0.007
-
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int. 2010 Jan; 105(1):58-66.
Score: 0.006
-
Pelvic organ prolapse: is there a difference in POPQ exam results based on time of day, morning or afternoon? Am J Obstet Gynecol. 2008 Aug; 199(2):200.e1-5.
Score: 0.006
-
Prediction of pelvic organ prolapse using an artificial neural network. Am J Obstet Gynecol. 2008 Aug; 199(2):193.e1-6.
Score: 0.005
-
Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun; 17(4):340-5.
Score: 0.005
-
Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol. 2004 Feb; 171(2 Pt 1):752-6.
Score: 0.004
-
Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol. 1996 Dec; 175(6):1467-70; discussion 1470-1.
Score: 0.002
-
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol. 1995 Jul; 173(1):72-9.
Score: 0.002